APOL1 and heart disorder: We suspect that differences in cardiac function would be particularly apparent in a model of heart disease such as heart failure with preserved ejection fraction (HFpEF), and suggest future research focuses on the effect of murine APOL1 genotype in HFpEF and related conditions.